Coloplast A/S (OTCMKTS:CLPBY) PT Raised to 835.00 at Barclays

Coloplast A/S (OTCMKTS:CLPBYGet Rating) had its target price hoisted by Barclays from 780.00 to 835.00 in a research note published on Tuesday morning, The Fly reports. The firm currently has an underweight rating on the stock.

Other analysts also recently issued research reports about the stock. UBS Group lowered their target price on shares of Coloplast A/S from 878.00 to 840.00 in a report on Tuesday, November 8th. Jefferies Financial Group downgraded shares of Coloplast A/S from a buy rating to a hold rating in a report on Tuesday, September 20th. Morgan Stanley initiated coverage on shares of Coloplast A/S in a report on Tuesday, October 18th. They issued an overweight rating for the company. Finally, Credit Suisse Group lowered their target price on shares of Coloplast A/S from 1,100.00 to 1,045.00 in a report on Wednesday, November 9th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat, Coloplast A/S has a consensus rating of Hold and an average price target of $925.00.

Coloplast A/S Stock Performance

Shares of CLPBY stock opened at $12.10 on Tuesday. The firm has a 50-day moving average of $10.94 and a 200-day moving average of $11.33. The company has a market cap of $26.14 billion, a P/E ratio of 40.33 and a beta of 0.28. The company has a debt-to-equity ratio of 0.02, a current ratio of 1.29 and a quick ratio of 0.90. Coloplast A/S has a one year low of $9.58 and a one year high of $17.99.

About Coloplast A/S

(Get Rating)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates in three segments: Chronic Care, Interventional Urology, and Wound & Skin Care. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand.

Further Reading

The Fly logo

Analyst Recommendations for Coloplast A/S (OTCMKTS:CLPBY)

Receive News & Ratings for Coloplast A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coloplast A/S and related companies with's FREE daily email newsletter.